000 | 01950 a2200577 4500 | ||
---|---|---|---|
005 | 20250514070602.0 | ||
264 | 0 | _c20030711 | |
008 | 200307s 0 0 eng d | ||
022 | _a0022-2623 | ||
024 | 7 |
_a10.1021/jm0205548 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAranapakam, Venkatesan | |
245 | 0 | 0 |
_aSynthesis and structure-activity relationship of alpha-sulfonylhydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis. _h[electronic resource] |
260 |
_bJournal of medicinal chemistry _cJun 2003 |
||
300 |
_a2361-75 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aADAM Proteins |
650 | 0 | 4 | _aADAM17 Protein |
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBiological Assay |
650 | 0 | 4 |
_aCartilage _xdrug effects |
650 | 0 | 4 | _aCattle |
650 | 0 | 4 | _aDialysis |
650 | 0 | 4 |
_aHydroxamic Acids _xchemical synthesis |
650 | 0 | 4 | _aMatrix Metalloproteinase 13 |
650 | 0 | 4 | _aMatrix Metalloproteinase Inhibitors |
650 | 0 | 4 |
_aMetalloendopeptidases _xantagonists & inhibitors |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aOsteoarthritis _xdrug therapy |
650 | 0 | 4 |
_aProtease Inhibitors _xchemical synthesis |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 |
_aSulfones _xchemical synthesis |
700 | 1 | _aGrosu, George T | |
700 | 1 | _aDavis, Jamie M | |
700 | 1 | _aHu, Baihua | |
700 | 1 | _aEllingboe, John | |
700 | 1 | _aBaker, Jannie L | |
700 | 1 | _aSkotnicki, Jerauld S | |
700 | 1 | _aZask, Arie | |
700 | 1 | _aDiJoseph, John F | |
700 | 1 | _aSung, Amy | |
700 | 1 | _aSharr, Michele A | |
700 | 1 | _aKillar, Loran M | |
700 | 1 | _aWalter, Thomas | |
700 | 1 | _aJin, Guixian | |
700 | 1 | _aCowling, Rebecca | |
773 | 0 |
_tJournal of medicinal chemistry _gvol. 46 _gno. 12 _gp. 2361-75 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm0205548 _zAvailable from publisher's website |
999 |
_c12559267 _d12559267 |